Toceranib (PHA 291639, SU 11654) 10mg

Toceranib is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFR??.

Trivial name Toceranib (PHA 291639, SU 11654) 10mg
Catalog Number A11581-10
Alternative Name(s) 5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide
Molecular Formula C22H25FN4O2
CAS# 356068-94-5
SMILES CC1=C(NC(=C1C(=O)NCCN2CCCC2)C)/C=C3/C4=C(C=CC(=C4)F)NC3=O
Size 10mg
Supplier Page http://www.adooq.com/toceranib-pha-291639-su-11654.html